The names of two Indian-Americans -- Seema Verma and Bobby Jindal -- have emerged as possible candidates.
.jpg)
As per the media report, the US Food and Drug Administration is learnt to have issued a Form 483 to the company's manufacturing facility at Mohali a few months ago after finding deviations from norms during an inspection of the plant.
Sun Pharma and Dr Reddy's top list in terms of those who face most class-action litigation
According to the petition copies, Hospira has alleged that Aurobindo's Abbreviated New Drug Application (ANDA) to make generic version of dexmedetomidine hydrochloride injection would infringe its patented drug Precedex.
Apple on Wednesday launched the Series 4 of the Watch and three phones -- iPhone XS, XS Max and XR -- at the Steve Jobs Theater in Cupertino, California.
An International Policy Network report in 2010 found that seven per cent of drugs bought from wholesale traders were substandard, and 3.6 per cent of the drugs from traders contained no active ingredient whatsoever.
Viveka Kumar lists the factors you need to keep in mind.
The state government had in the first week of June banned Maggi sale in the state after the product failed the food safety test.
Accenture -- considered as one of the top-most employers in India among the global technology services companies -- is believed to have over 150,000 workers in India, next to IBM.
'Nothing in this world is permanent. So also in business.' 'And more so in family businesses where family issues often influence business decisions,' point out S Subramanian and Nupur Pavan Bang.
'Sharapova has been a US resident since early in her career, which does bring in a question of how or why she is using a drug that is not licensed there'
It hopes to turn around Ranbaxy within four years of closing the deal by improving efficiency and resolving all regulatory issues
A huge stock of Maggi noodles was destroyed by Nestle after the ban was imposed by the food regulators.
Pharma major Ranbaxy Laboratories has set aside Rs 257.4 crore (Rs 2.57 billion) towards the financial impact of a US ban on import of products made at its plant at Toansa.
Nestle now has less than two weeks to convince the regulator why product approval for its noodles should not be withdrawn
IT, pharma and FMCG stocks are the top performers in 2013.
Sun Pharma profit down 30% over compliance costs, lower sales.
While the US health regulator did not specify details for issuing the alert, it said 'detention without physical examination may be appropriate when an FDA inspection has revealed that a firm is not operating in conformity with current good manufacturing practices'.
The company spokesperson expressed disappointment with the "unprecedented step of filing of a complaint before the NCDRC"
.jpg)
The report comes at a time when the government is trying to clear pending FDI proposals, which include various planned investments in this sector.
While Reliance Retail did not comment, sources said the company will have to follow order, at least in Delhi.
market, was today seized from an illegal drug manufacturing unit in Jalgaon district in north Maharashtra and six persons were arrested, Directorate of Revenue Intelligence officials said.
The combined sales of the branded versions of the products in the US is about $3.5 billion.
DRL launched four new products in North America during the previous quarter.
4 Ranbaxy facilities in India have been barred from exporting to US.
In India, thousands of lives are lost every year because of unavailability of organs
According to Munjal, there is an opportunity for somebody who comes from a not for profit background in health care to do something.
In a surprise announcement in April, Sun and Ranbaxy -- at that time owned by Japan's Daiichi -- declared an all-stock deal to create India's largest and world's fifth-largest drugmaker in an over $4 billion deal.
A look at the top tweets from your favourite Bollywood celebrities.
Sun Pharma's offer was tempting because Ranbaxy was too busy fighting fires in the US to concentrate on operations.
Amneal Pharmaceuticals is set to pip Sun Pharma as the fifth largest generics maker in the US, reports Sohini Das.
Lack of clarity on whether manufacturing bans in Punjab, Uttarakhand, Himachal, Goa and Karnataka still in place
Competition in the US pharmaceutical market swelled in recent years, with increasing generic penetration.
'India easily remains one among the more attractive large economies, with high growth and stable/improving macros, as a top investment destination.' 'We are looking pretty good.'
Details on prices sought as 10 generic drugs become up to 83 times costlier in 6 months
'The mismatch between valuations and fundamentals is startling,' warns Devangshu Datta
Sun Pharmaceutical, which is growing its dermatology and ophthalmic specialty business in the US will spend $460 million on R&D.
The US Drug maker requested the court to pass an order to restrain DRL from commercially manufacturing, using, offering for sale, selling, marketing, distributing, or importing DRL's generic paricalcitol injectable products prior to the expiration of said patents.
It was a disturbing message in the sense that the regulatory framework is not clear enough and is not always applied in a convincing manner.
With global markets pushing ahead, enthused by strengthening US jobs market, and also due to prospects of European rate hike, Indian markets also continued the march ahead.
